- Home
- USM vs RNA Comparison
USM vs RNA Comparison
Compare USM & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USM
- RNA
- Stock Information
- Founded
- USM 1983
- RNA 2012
- Country
- USM United States
- RNA United States
- Employees
- USM N/A
- RNA N/A
- Industry
- USM Telecommunications Equipment
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- USM Telecommunications
- RNA Health Care
- Exchange
- USM Nasdaq
- RNA Nasdaq
- Market Cap
- USM 5.4B
- RNA 5.5B
- IPO Year
- USM 1988
- RNA 2020
- Fundamental
- Price
- USM $61.35
- RNA $42.18
- Analyst Decision
- USM Buy
- RNA Strong Buy
- Analyst Count
- USM 3
- RNA 9
- Target Price
- USM $80.00
- RNA $63.22
- AVG Volume (30 Days)
- USM 202.2K
- RNA 1.1M
- Earning Date
- USM 11-01-2024
- RNA 11-07-2024
- Dividend Yield
- USM N/A
- RNA N/A
- EPS Growth
- USM N/A
- RNA N/A
- EPS
- USM N/A
- RNA N/A
- Revenue
- USM $3,799,000,000.00
- RNA $10,117,000.00
- Revenue This Year
- USM N/A
- RNA $19.33
- Revenue Next Year
- USM N/A
- RNA $10.35
- P/E Ratio
- USM N/A
- RNA N/A
- Revenue Growth
- USM N/A
- RNA N/A
- 52 Week Low
- USM $32.01
- RNA $5.68
- 52 Week High
- USM $68.31
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- USM 54.08
- RNA 42.17
- Support Level
- USM $60.62
- RNA $45.65
- Resistance Level
- USM $66.49
- RNA $56.00
- Average True Range (ATR)
- USM 2.42
- RNA 3.33
- MACD
- USM -0.16
- RNA 0.07
- Stochastic Oscillator
- USM 50.21
- RNA 7.12
About USM United States Cellular Corporation
us Cellular is a regional wireless carrier that serves about 4.5 million customers spread across four major geographic clusters: the Midwest, mid-Atlantic, New England, and the Pacific Northwest. These service territories encompass a total population of about 32 million people. The vast majority of the markets the firm serves are rural or second/third-tier cities, with only the greater Milwaukee and Oklahoma City regions boasting populations greater than 1 million. us Cellular also owns a 5.5% stake in Verizon Wireless' Los Angeles operations and, unlike its wireless carrier peers, owns most of its own towers. The firm has agreed to sell its wireless operations and 30% of its wireless spectrum licenses to T-Mobile, a transaction that it expects to close in mid-2025.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.